H. Thomas

Surgical and chemotherapeutic treatment of hepatic metastases from carcinoma of the breast.

D. Elias, P. Lasser, M. Spielmann, 1991, Surgery, gynecology & obstetrics.

Modern chemotherapy management of recurrent ovarian cancer: a multicentre study.

F. Percival, S. Chan, S. Awwad, 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First Study.

C. Steer, D. Yip, P. Harper, 2006, Gynecologic oncology.

Docetaxel and cisplatin in combination as first-line chemotherapy for advanced epithelial ovarian cancer. Scottish Gynaecological Cancer Trials Group.

J. Graham, S. M. Crawford, P. Vasey, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

An analysis of possible prognostic features of long term and short term survivors of metastatic breast cancer.

T. Powles, R. Coombes, J. Gibb, 1986, European journal of cancer & clinical oncology.

Postoperative Chemotherapy May Not Be Necessary for Patients With ypN0-Category After Neoadjuvant Chemoradiotherapy of Rectal Cancer

G. Kundt, M. Barten, R. Fietkau, 2006, Diseases of the colon and rectum.

Clinical outcomes of neoadjuvant chemotherapy and primary debulking surgery in advanced ovarian carcinoma.

A. Taylor, S. Butler-Manuel, H. Thomas, 2006, European journal of gynaecological oncology.